Newsroom

Filters: press-releases
x

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

Biosimilar Medicines for Rheumatologists: Bridging the Gap between Regulatory Science and Medical Societies

10 June 2016

Over the past decade, biosimilar medicines have generated more than […]

Read more

Generic, Biosimilar and Value Added Medicines Industry Leaders Join Forces to Drive Access to Medicines Agenda

9 June 2016

During the next two days, the key pharmaceutical industry leaders […]

Read more

Value Added Medicines: Rethink, Reinvent & Optimise Medicines, Improving Patient Health & Access

31 May 2016

A new study Value Added Medicines: Rethink, Reinvent & Optimise […]

Read more

Medicines for Europe Joins Global Campaign to Fight Fake Medicines

27 May 2016

Medicines for Europe, the voice of the generic, biosimilar and […]

Read more

The European Parliament Votes for Jobs in the EU Generic and Biosimilar Medicines Industries

26 May 2016

Medicines for Europe, the voice of the generic, biosimilar and […]

Read more

Biosimilar Medicines for Rheumatologists: Understanding the Science of Extrapolation / 10th June 2016, 08:15–09:45 Capital Suite 09, ExCel London

17 May 2016

Open

Value Added Medicines: Rethink, Reinvent & Optimise Medicines, Improving Patient Health & Access / 31 May 2016 17:30 – 19:30, European Parliament

4 May 2016

Open

10 Years of Biosimilar Medicines: Transforming Healthcare

28 April 2016

Biosimilar medicines provide an opportunity to increase patient access to […]

Read more

The European Parliament Calls on the Commission to Boost Manufacturing and Export of EU Generic and Biosimilar Medicines

21 April 2016

Launched on 28 October 2015 , the European Commission’s new […]

Read more

6 out of 10 Doctors Have Already Prescribed Biosimilar Medicines, According to EuropaBio Paper

20 April 2016

Medicines for Europe and its Biosimilar Medicines Group took note […]

Read more

Subscribe to our newsletter